Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

Approximately 15 to 20 million Americans who have acquired COVID-19 experience persistent symptoms lasting over 3 months (long-COVID). Respiratory symptoms of long-COVID include breathlessness, ...

Early Phase 2a data suggest the IPF therapy GRI-0621 alters gene activity tied to inflammation, scarring, and tissue repair.

By Dr. Priyom Bose, Ph.D. By replacing both breathing and circulatory buffering, a novel artificial lung bought critical time after lung removal, revealed irreversible damage, and made transplantation ...

Khaberni - In an unprecedented medical achievement, doctors and surgeons at Northwestern Medicine in Chicago managed to keep a critical patient alive for 48 hours after ...